Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390101 | SCV001591722 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu943*) in the NBAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBAS are known to be pathogenic (PMID: 26073778, 26541327, 27789416, 28031453). This variant is present in population databases (rs143012720, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with SOPH syndrome and acute liver failure (PMID: 26073778, 28031453, 31761904). ClinVar contains an entry for this variant (Variation ID: 1076261). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001390101 | SCV005079647 | pathogenic | not provided | 2023-07-07 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31980526, 34426522, 30825388, 27789416, 28031453, 26073778, 31761904, 26541327) |
Hudson |
RCV004671382 | SCV005093829 | pathogenic | Infantile liver failure syndrome 2 | 2024-01-29 | criteria provided, single submitter | research | |
Mayo Clinic Laboratories, |
RCV001390101 | SCV005414327 | pathogenic | not provided | 2023-11-09 | criteria provided, single submitter | clinical testing | PM3, PVS1 |